KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $29.1 million.

  • Medpace Holdings' Change in Receivables rose 29049.36% to $29.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $106.2 million, marking a year-over-year increase of 483751.12%. This contributed to the annual value of $106.2 million for FY2025, which is 483751.12% up from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' Change in Receivables is $29.1 million, which was up 29049.36% from -$4.9 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Change in Receivables peaked at $79.9 million during Q2 2025, and registered a low of -$19.1 million during Q1 2024.
  • Moreover, its 5-year median value for Change in Receivables was $6.7 million (2022), whereas its average is $12.2 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 710312.5% in 2022, then tumbled by 54005.52% in 2024.
  • Medpace Holdings' Change in Receivables (Quarter) stood at -$64000.0 in 2021, then surged by 7103.12% to $4.5 million in 2022, then skyrocketed by 100.09% to $9.0 million in 2023, then plummeted by 270.32% to -$15.3 million in 2024, then surged by 290.49% to $29.1 million in 2025.
  • Its Change in Receivables was $29.1 million in Q4 2025, compared to -$4.9 million in Q3 2025 and $79.9 million in Q2 2025.